Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Oncology
Oncolog, Volume 58, Number 08, August 2013, Bryan Tutt, Sarah Bronson
Oncolog, Volume 58, Number 08, August 2013, Bryan Tutt, Sarah Bronson
OncoLog MD Anderson's Report to Physicians (All issues)
- Specialized Care Improves Lives of patients With Head and Neck Lymphedema: A unique program is producing dramatic results for patients with head and neck lymphedema, a side effect of cancer treatment that can interfere with patient's ability to speak, swallow, or breath
- Targeted Cancer Therapies May Help Overcome Resistance to Radiation Therapy: Some cancer cells are resilient enough to withstand and recover from the damage to their DNA caused by radiation therapy. But recent studies have shown that adding molecularly targeted agents to radiation therapy can prevent the repair of this radiation-induced damage and therapy improve the treatment response of …
Oncolog, Volume 58, Number 03, March 2013, Sarah Bronson, Zach Bohannan, Bryan Tutt
Oncolog, Volume 58, Number 03, March 2013, Sarah Bronson, Zach Bohannan, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Advances in Pulmonary Medicine Facilitate Cancer Diagnosis, Treatment: The lungs present unique challenges in cancer diagnosis and treatment-navigating a maze of bronchi to find and sample tissue that will lead to an accurate diagnosis of lung cancer, for example, or deciding whether to proceed with treatment for cancer in the presence of concomitant lung disease
- New Drugs Increase Treatment Options for Patients with Imatinib-Resistant Chronic Myeloid Leukemia: In the past year, several new targeted drugs have been approved as second-line treatments for imatinib-resistant chronic myeloid leukemia (CML). These drugs include the second-generation tyrosine kinase inhibitor bosutinib and the third-generation tyrosine …